Patient-reported, Health Economic and Psychosocial Outcomes in Friedreich Ataxia
Condition(s) studied
Study summary
The PROFA study is an international, multi-centric observational and validation study to assess the patient-reported, psychosocial and economic outcomes of patients with Friedreich Ataxia (FA). Eligible patients will be recruited from six study centers in Germany, Austria and France. Patients will complete a baseline assessment via face-to-face interviews at the study centers and multiple momentary follow-up assessments via a mobile-health app at home daily to monthly for six months. Study results will gain essential and in-depth insights into the daily life of patients with FA.
Eligibility
Primary outcome measure(s)
- Usability of the mobile-health app as a remote monitoring momentary data assessment tool — Six months
Completeness of data - Acceptability of the mobile-health app as a remote monitoring momentary data assessment tool — Month 6
Acceptability is assessed by a self-developed questionnaire (asking patients to rate the app based on user experience) - Total societal costs — Six months
Aggregated healthcare costs of utilized healthcare services, informal care and productivity losses - Health-related quality of life — Month 1
Health-related quality of life assessed by the "Patient Reported Outcome Measures for Ataxia" Short-Form (PROM-ATAX), with a score range between 0 to 40 with higher scores indicating lower health-related quality of life - Health-related quality of life — Month 3
Health-related quality of life assessed by the "Patient Reported Outcome Measures for Ataxia" Short-Form (PROM-ATAX), with a score range between 0 to 40 with higher scores indicating lower health-related quality of life - Health-related quality of life — Month 5
Health-related quality of life assessed by the "Patient Reported Outcome Measures for Ataxia" Short-Form (PROM-ATAX), with a score range between 0 to 40 with higher scores indicating lower health-related quality of life - Health-related quality of life — Month 6
Health-related quality of life assessed by the "Patient Reported Outcome Measures for Ataxia" Short-Form (PROM-ATAX), with a score range between 0 to 40 with higher scores indicating lower health-related quality of life - Psychosocial health due to communication handicaps caused by speech and hearing disabilities — Month 1
Psychosocial impact of hearing and speech disabilities assessed by the "Scale for the psychosocial impact of hearing and speech disabilities in Friedreich Ataxia" (COM-ATAX) with a score range between 0 to 68 (higher scores indicate more difficulties) - Psychosocial health due to communication handicaps caused by speech and hearing disabilities — Month 2
Psychosocial impact of hearing and speech disabilities assessed by the "Scale for the psychosocial impact of hearing and speech disabilities in Friedreich Ataxia" (COM-ATAX) with a score range between 0 to 68 (higher scores indicate more difficulties) - Psychosocial health due to communication handicaps caused by speech and hearing disabilities — Month 3
Psychosocial impact of hearing and speech disabilities assessed by the "Scale for the psychosocial impact of hearing and speech disabilities in Friedreich Ataxia" (COM-ATAX) with a score range between 0 to 68 (higher scores indicate more difficulties) - Psychosocial health due to communication handicaps caused by speech and hearing disabilities — Month 4
Psychosocial impact of hearing and speech disabilities assessed by the "Scale for the psychosocial impact of hearing and speech disabilities in Friedreich Ataxia" (COM-ATAX) with a score range between 0 to 68 (higher scores indicate more difficulties) - Psychosocial health due to communication handicaps caused by speech and hearing disabilities — Month 5
Psychosocial impact of hearing and speech disabilities assessed by the "Scale for the psychosocial impact of hearing and speech disabilities in Friedreich Ataxia" (COM-ATAX) with a score range between 0 to 68 (higher scores indicate more difficulties) - Psychosocial health due to communication handicaps caused by speech and hearing disabilities — Month 6
Psychosocial impact of hearing and speech disabilities assessed by the "Scale for the psychosocial impact of hearing and speech disabilities in Friedreich Ataxia" (COM-ATAX) with a score range between 0 to 68 (higher scores indicate more difficulties) - Fluctuation of health-related quality of life — Day one, two and three in months 1
Change in health-related quality of life measured by the 5-level EQ-5D version (EQ-5D-5L) with a score range between 0 and 1 (higher values indicate higher health-related quality of life) - Fluctuation of health-related quality of life — Day one, two and three in months 3
Change in health-related quality of life measured by the 5-level EQ-5D version (EQ-5D-5L) with a score range between 0 and 1 (higher values indicate higher health-related quality of life) - Fluctuation of health-related quality of life — Day one, two and three in months 5
Change in health-related quality of life measured by the 5-level EQ-5D version (EQ-5D-5L) with a score range between 0 and 1 (higher values indicate higher health-related quality of life) - Fluctuation of health-related quality of life — Day one, two and three in months 6
Change in health-related quality of life measured by the 5-level EQ-5D version (EQ-5D-5L) with a score range between 0 and 1 (higher values indicate higher health-related quality of life)
Trial sites (6)
| Facility | City | Region | Status |
|---|---|---|---|
| Klinik für Neurologie, Medizinische Universität Innsbruck | Innsbruck | Austria | Recruiting |
| Paris Brain Institute | Paris | France | Recruiting |
| Department of Neurology, RWTH Aachen University | Aachen | Germany | Recruiting |
| German Center for Neuro-degenerative Diseases (DZNE) | Bonn | Germany | Recruiting |
| Friedrich-Baur-Institut an der Neurologischen Klinik und Poliklinik | Münich | Germany | Recruiting |
| Neurologische Klinik und Hertie-Institut für Klinische Hirnforschung, Universitätsklinik Tübingen | Tübingen | Germany | Not Yet Recruiting |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05943002 on ClinicalTrials.gov ↗ ← All trials in Austria